Search Results - "Ocean, A." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial

by Bardia, A., Messersmith, W.A., Kio, E.A., Berlin, J.D., Vahdat, L., Masters, G.A., Moroose, R., Santin, A.D., Kalinsky, K., Picozzi, V., O'Shaughnessy, J., Gray, J.E., Komiya, T., Lang, J.M., Chang, J.C., Starodub, A., Goldenberg, D.M., Sharkey, R.M., Maliakal, P., Hong, Q., Wegener, W.A., Goswami, T., Ocean, A.J.
Published in Annals of oncology (01.06.2021)

Get full text

Journal Article

SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC)

SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC)

by Noel, M., Wang-Gillam, A., Ocean, A., Chawla, S., Chung, V., DelPriore, G., Picozzi, V.
Published in Annals of oncology (01.07.2019)

Get full text

Journal Article

RENCA macrobead therapy (RMB): A biological-systems approach to metastatic colorectal cancer [U.S. FDA BB-IND 10091]

RENCA macrobead therapy (RMB): A biological-systems approach to metastatic colorectal cancer [U.S. FDA BB-IND 10091]

by Nazarian, A., Sureshbabu, S., Berman, N., Wolf, D., Gazda, L., Fahey, T., Ocean, A., Smith, B.
Published in Annals of oncology (01.07.2019)

Get full text

Journal Article

Dose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results

Dose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results

by Goel, S, Ocean, A, Parakrama, R, Ghalib, M H, Chaudhary, I, Shah, U, Coffey, M, Kaledzi, E, Maitra, R
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

RMB (RENCA Macrobead) therapy in advanced mCRC: Phase IIb preliminary multi-site survival findings; correlation & combination with Phase I and IIa data including imaging and lab profiles [U.S.FDA BB-IND 10091]

RMB (RENCA Macrobead) therapy in advanced mCRC: Phase IIb preliminary multi-site survival findings; correlation & combination with Phase I and IIa data including imaging and lab profiles [U.S.FDA BB-IND 10091]

by Nazarian, A., Andrada, Z., Thomas, J., Sureshbabu, S., Berman, N., Wolf, D., Gazda, L., Fahey, T., Ocean, A., Smith, B.
Published in Annals of oncology (01.06.2018)

Get full text

Journal Article

Open-label, multicenter, single-arm study of FABLOx (metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin) in patients with metastatic pancreatic cancer: Phase I results

Open-label, multicenter, single-arm study of FABLOx (metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin) in patients with metastatic pancreatic cancer: Phase I results

by Sahai, V., Saif, W., Kalyan, A., Philip, P., Rocha-Lima, C., Ocean, A., Ondovik, M., Simeone, D., Karnoub, M., Louis, C., Picozzi, V.
Published in Annals of oncology (01.06.2018)

Get full text

Journal Article

Machine Learning-Based Intrusion Detection System for the Internet of Vehicles

Machine Learning-Based Intrusion Detection System for the Internet of Vehicles

by Pradhan, Manabhanjan, Mohanty, Sujata, Seemona, A. Ocean
Published in 2022 5th International Conference on Computational Intelligence and Networks (CINE) (01.12.2022)

Get full text

Conference Proceeding

Bevacizumab in unresectable hepatocellular carcinoma (HCC) for patients without metastasis and without invasion of the portal vein

Bevacizumab in unresectable hepatocellular carcinoma (HCC) for patients without metastasis and without invasion of the portal vein

by Schwartz, J. D., Schwartz, M., Lehrer, D., Cohen, E., Sung, M., Kinkhabwala, M., Siegel, A., Holloway, S., Ocean, A., Wadler, S.
Published in Journal of clinical oncology (20.06.2006)

Get full text

Journal Article

8MO Neoadjuvant botensilimab (BOT) plus balstilimab (BAL) in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial

8MO Neoadjuvant botensilimab (BOT) plus balstilimab (BAL) in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial

by Kasi, P.M., Jafari, M.D., Yeo, H., Lowenfeld, L., Khan, U., Nguyen, A., Siolas, D., Swed, B., Khan, S., Wood, M., Ocean, A., Popa, E., Garrett, K., Golden, E., Guniganti, P., Zhou, X.K., Pigazzi, A., Shah, M.A., Hissong, E., Hidalgo, M.
Published in Annals of oncology (01.06.2024)

Get full text

Journal Article

P-059SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC)

P-059SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC)

by Noel, M, Wang-Gillam, A, Ocean, A, Chawla, S, Chung, V, DelPriore, G, Picozzi, V
Published in Annals of oncology (01.07.2019)

Get full text

Journal Article

P-232RENCA macrobead therapy (RMB): A biological-systems approach to metastatic colorectal cancer [U.S. FDA BB-IND 10091]

P-232RENCA macrobead therapy (RMB): A biological-systems approach to metastatic colorectal cancer [U.S. FDA BB-IND 10091]

by Nazarian, A, Sureshbabu, S, Berman, N, Wolf, D, Gazda, L, Fahey, T, Ocean, A, Smith, B
Published in Annals of oncology (01.07.2019)

Get full text

Journal Article

719PPhase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

719PPhase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

by Ocean, A, Noel, M, Wang-Gillam, A, Chawla, S, Chung, V, Pant, S, Korn, R, Priore, G Del, Picozzi, V
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Phase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

Phase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

by Ocean, A., Noel, M., Wang-Gillam, A., Chawla, S., Chung, V., Pant, S., Korn, R., De Priore, G.l., Picozzi, V.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

719P - Phase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

719P - Phase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

by Ocean, A., Noel, M., Wang-Gillam, A., Chawla, S., Chung, V., Pant, S., Korn, R., De Priore, G.l., Picozzi, V.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

565PDose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results

565PDose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results

by Goel, S, Ocean, A, Parakrama, R, Ghalib, M H, Chaudhary, I, Shah, U, Coffey, M, Kaledzi, E, Maitra, R
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

PD-019RMB (RENCA Macrobead) therapy in advanced mCRC: Phase IIb preliminary multi-site survival findings; correlation & combination with Phase I and IIa data including imaging and lab profiles [U.S.FDA BB-IND 10091]

PD-019RMB (RENCA Macrobead) therapy in advanced mCRC: Phase IIb preliminary multi-site survival findings; correlation & combination with Phase I and IIa data including imaging and lab profiles [U.S.FDA BB-IND 10091]

by Nazarian, A, Andrada, Z, Thomas, J, Sureshbabu, S, Berman, N, Wolf, D, Gazda, L, Fahey, T, Ocean, A, Smith, B
Published in Annals of oncology (01.06.2018)

Get full text

Journal Article

Mechanism of pelareorep (Pel)-mediated cell death in a Phase I study in combination with irinotecan/fluorouracil/leucovorin/bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC)

Mechanism of pelareorep (Pel)-mediated cell death in a Phase I study in combination with irinotecan/fluorouracil/leucovorin/bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC)

by Goel, S., Ocean, A., Chaudhary, I., Ghalib, M.H., Kaledzi, E., Shah, U., Gutierrez, A.A., Coffey, M., Gill, G., Maitra, R.
Published in Annals of oncology (01.09.2017)

Get full text

Journal Article

P-155Open-label, multicenter, single-arm study of FABLOx (metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin) in patients with metastatic pancreatic cancer: Phase I results

P-155Open-label, multicenter, single-arm study of FABLOx (metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin) in patients with metastatic pancreatic cancer: Phase I results

by Sahai, V, Saif, W, Kalyan, A, Philip, P, Rocha-Lima, C, Ocean, A, Ondovik, M, Simeone, D, Karnoub, M, Louis, C, Picozzi, V
Published in Annals of oncology (01.06.2018)

Get full text

Journal Article

P-162 Interim Results of IMMU-132 (Sacituzumab Govitecan), an Anti-Trop-2 Antibody-Drug Conjugate (ADC), in Patients (pts) with Metastatic Gastrointestinal (GI) Cancers

P-162 Interim Results of IMMU-132 (Sacituzumab Govitecan), an Anti-Trop-2 Antibody-Drug Conjugate (ADC), in Patients (pts) with Metastatic Gastrointestinal (GI) Cancers

by Ocean, A., Starodub, A., Messersmith, W., Picozzi, V., Guarino, M., Thomas, S., Bardia, A., Shah, M., Govindan, S., Maliakal, P., Wegener, W., Sharkey, R., Wilhelm, F., Goldenberg, D.
Published in Annals of oncology (01.06.2015)

Get full text

Journal Article

Treatment of advanced, epithelial-derived cancer (AEC) with intraperitoneal implantation of agarose-agarose macrobeads (MB) containing mouse renal adenocarcinoma cells (RENCA)

Treatment of advanced, epithelial-derived cancer (AEC) with intraperitoneal implantation of agarose-agarose macrobeads (MB) containing mouse renal adenocarcinoma cells (RENCA)

by Keir, C. H., Ocean, A. J., Fahey, T. J., Berman, N., Wadke, A., Kelly-Rossini, L., Goldstein, M. J., Leeser, D. B., Michelassi, F., Smith, B. H.
Published in Journal of clinical oncology (20.05.2011)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[12]